Mefloquine

What is Mefloquine?

Mefloquine is a potent synthetic antimalarial drug primarily used for the prevention (prophylaxis) and treatment of malaria. It belongs to a class of medications known as quinoline-methanol derivatives. Developed by the U.S. Army in the 1970s, Mefloquine has been a critical tool in combating malaria, particularly in regions where other antimalarials like chloroquine have become ineffective due to parasite resistance. It is often prescribed for travelers visiting areas with a high risk of malaria transmission and for individuals residing in such areas.

Known by its brand name, Lariam, Mefloquine is effective against various strains of the malaria parasite, including Plasmodium falciparum and Plasmodium vivax. Its sustained action makes it suitable for weekly dosing, which is convenient for long-term prophylaxis. However, its use is carefully considered due to a profile of potential side effects, especially neuropsychiatric ones, which necessitate a thorough medical evaluation before prescription.

How Does it Work?

Mefloquine exerts its antimalarial action by targeting the blood stages of the malaria parasite. Once ingested, it is absorbed and widely distributed throughout the body, including red blood cells, where the malaria parasites multiply. The precise mechanism of action is not fully understood but is believed to involve several key processes:

• Heme Detoxification Inhibition: Malaria parasites digest hemoglobin within red blood cells, producing toxic heme. To neutralize this, parasites polymerize heme into a non-toxic pigment called hemozoin. Mefloquine is thought to interfere with this critical detoxification process, leading to an accumulation of toxic heme within the parasite, ultimately causing its death.
• Membrane Damage: Some research suggests that Mefloquine may also directly damage the parasite's cell membranes, disrupting its ability to maintain cellular integrity and function.
• Nucleic Acid Synthesis Interference: There is also evidence that Mefloquine can interfere with the parasite's nucleic acid synthesis, thereby inhibiting its growth and replication.

By disrupting these vital processes, Mefloquine effectively kills the parasites, reducing the parasitic load and alleviating malaria symptoms or preventing the disease from taking hold.

Medical Uses

The primary medical uses of Mefloquine revolve around the prevention and treatment of malaria:

• Malaria Prophylaxis (Prevention)

  Mefloquine is widely used for malaria prevention in individuals traveling to or residing in malaria-endemic areas, particularly those with chloroquine-resistant P. falciparum. It is typically started one to two weeks before travel, continued throughout the stay, and for four weeks after leaving the endemic area. This regimen ensures that sufficient drug levels are maintained in the blood to kill any parasites acquired during exposure.

• Treatment of Acute, Uncomplicated Malaria

  Mefloquine is also prescribed for the treatment of acute, uncomplicated malaria caused by susceptible strains of Plasmodium falciparum or Plasmodium vivax. It is particularly valuable in cases of chloroquine-resistant malaria. The treatment course is generally shorter than prophylaxis, often involving a single or divided dose over a few days, depending on the patient's condition and the specific malarial strain.

It is important to note that Mefloquine is not effective against the liver stage of the parasite (hypnozoites) of P. vivax and P. ovale, meaning it may not prevent relapses from these species. For such cases, additional medication like primaquine may be required.

Dosage

The dosage of Mefloquine varies significantly based on whether it is being used for malaria prophylaxis or treatment, as well as the patient's age and weight. It is crucial to follow a healthcare professional's specific instructions.

• For Malaria Prophylaxis (Adults)

  The typical adult prophylactic dose is 250 mg taken orally once a week. Dosing should begin 1-2 weeks before entering a malaria-endemic area, continue once weekly during the entire stay, and for four consecutive weeks after leaving the area. Taking the dose with food and a full glass of water can help minimize gastrointestinal upset.

• For Treatment of Acute, Uncomplicated Malaria (Adults)

  For treating acute malaria, the usual adult dose is 1250 mg (five 250 mg tablets) taken as a single dose. Alternatively, it can be given as 750 mg initially, followed by 500 mg 6-12 hours later. This divided dose regimen may reduce the incidence of side effects. For children, the dosage is calculated based on body weight.

It is paramount to complete the full course of treatment or prophylaxis as prescribed, even if symptoms improve, to ensure full efficacy and prevent drug resistance.

Side Effects

While an effective antimalarial drug, Mefloquine is known for a range of potential side effects, some of which can be serious. This is why its use requires careful consideration and patient monitoring.

• Common Side Effects

  These are generally mild and may include nausea, vomiting, dizziness, headache, sleep disturbances (insomnia or vivid dreams), and diarrhea. Taking the medication with food can help mitigate gastrointestinal symptoms.

• Neuropsychiatric Side Effects

  Mefloquine carries a prominent warning regarding potentially severe and long-lasting neuropsychiatric side effects. These can include anxiety, depression, panic attacks, paranoia, hallucinations, psychosis, and seizures. These symptoms can occur during or after treatment and may persist for months or years after discontinuation. Patients with a history of depression, anxiety disorders, psychosis, or seizures are generally advised against using Mefloquine.

• Other Serious Side Effects

  Less common but serious side effects can include cardiac arrhythmias (irregular heartbeat), bradycardia (slow heart rate), and severe allergic reactions. If any severe or concerning side effects occur, medical attention should be sought immediately.

Due to the potential for significant adverse reactions, it is crucial to discuss all existing medical conditions and medications with your doctor before starting Mefloquine.

Drug Interactions

Mefloquine can interact with several other medications, potentially altering its effectiveness or increasing the risk of adverse effects. Always inform your healthcare provider about all prescription, over-the-counter, and herbal supplements you are taking.

• Other Antimalarials: Co-administration with quinine, quinidine, or chloroquine can increase the risk of seizures and ECG abnormalities. If these drugs are used sequentially, a washout period may be necessary.
• Beta-Blockers and Calcium Channel Blockers: Mefloquine can prolong the QTc interval on an electrocardiogram. Concomitant use with drugs that also prolong the QTc interval (e.g., beta-blockers, certain antiarrhythmics) can increase the risk of serious cardiac arrhythmias.
• Anticonvulsants: Mefloquine may lower the seizure threshold, potentially reducing the effectiveness of anticonvulsant medications. Close monitoring of seizure activity may be required.
• Live Oral Typhoid Vaccine: Mefloquine may reduce the immune response to the live oral typhoid vaccine. It is generally recommended to complete the typhoid vaccination at least 24 hours before the first dose of Mefloquine.
• Warfarin: Mefloquine may alter the anticoagulant effect of warfarin. Increased monitoring of INR (International Normalized Ratio) is advised if these medications are used together.
• Other Medications: Interactions with certain antidepressants (SSRIs), antibiotics (rifampin), and HIV medications (ritonavir) have also been reported or are theoretically possible.

Given these potential interactions, a thorough medication review is essential before initiating Mefloquine.

FAQ

• Is Mefloquine safe for everyone?

  No, Mefloquine is not suitable for everyone. It is contraindicated in individuals with a history of depression, anxiety disorders, psychosis, seizures, or other severe neuropsychiatric conditions. Pregnant women, especially in the first trimester, and individuals with certain heart conditions or liver impairment may also need alternative antimalarial options.

• How long do I need to take Mefloquine for malaria prevention?

  For malaria prevention, Mefloquine is typically started 1-2 weeks before travel, continued weekly throughout your stay in the malaria-risk area, and for four weeks after leaving the area. This ensures continuous protection.

• Can Mefloquine cause nightmares or vivid dreams?

  Yes, vivid dreams and nightmares are among the common neuropsychiatric side effects reported with Mefloquine. Some individuals may experience these effects, which can range from mild to distressing.

• Is Mefloquine effective against all types of malaria?

  Mefloquine is highly effective against drug-sensitive strains of Plasmodium falciparum and Plasmodium vivax. However, resistance to Mefloquine can occur in some regions. It is not effective against the liver stages of P. vivax and P. ovale, so it won't prevent relapses from these species.

• What should I do if I miss a dose of Mefloquine?

  If you miss a dose for prophylaxis, take it as soon as you remember, then continue your weekly schedule. Do not take two doses at once. If you miss a dose for treatment, contact your doctor for advice.

Products containing Mefloquine are available through trusted online pharmacies. You can browse Mefloquine-based medications at ShipperVIP or Medicenter.

Summary

Mefloquine is a vital antimalarial drug with a significant role in global health, particularly for the malaria prevention and malaria treatment of drug-resistant strains. While highly effective, its use requires careful consideration due to its notable profile of potential side effects, especially neuropsychiatric ones. Patients considering Mefloquine should undergo a thorough medical evaluation, including a review of their medical history and current medications, to assess suitability and minimize risks. Adherence to prescribed dosages and awareness of potential interactions are crucial for maximizing its benefits while mitigating adverse effects. Always consult a healthcare professional for personalized advice regarding Mefloquine or any other antimalarial medication.